MED-10~statin breast cancer surviv nationwid cohort studi finland abstract recent studi suggest statin establish drug group prevent cardiovascular mortal delay prevent breast cancer recurr effect disease-specif mortal remain unclear evalu risk breast cancer death statin user population-bas cohort breast cancer patient studi cohort includ newli diagnos breast cancer patient finland num num num case identifi finnish cancer registri inform statin diagnosi obtain nation prescript databas cox proport hazard regress method estim mortal statin user statin time-depend variabl total num particip statin median follow-up num year diagnosi rang num num year num particip die num num due breast cancer adjust age tumor characterist treatment select post-diagnost pre-diagnost statin lower risk breast cancer death hr num num ci num num hr num num ci num num risk decreas post-diagnost statin affect healthi adher bias greater likelihood die cancer patient discontinu statin associ dose-depend observ low-dose/short-term dose time-depend surviv benefit pre-diagnost statin user suggest causal effect evalu clinic trial test statin effect surviv breast cancer patient	
MED-14~statin diagnosi breast cancer surviv population-bas cohort studi pubm ncbi abstract background preclin studi shown statin simvastatin prevent growth breast cancer cell line anim model investig statin breast cancer diagnosi reduc risk breast cancer-specif all-caus mortal larg cohort breast cancer patient method cohort num breast cancer patient newli diagnos num num identifi english cancer registri nation cancer data repositori cohort link uk clinic practic research datalink provid prescript record offic nation statist mortal data num identifi num death includ num death attribut breast cancer unadjust adjust hazard ratio hrs breast cancer-specif all-caus mortal statin user breast cancer diagnosi calcul time-depend cox regress model sensit analys conduct multipl imput method propens score method case-control approach result evid statin diagnosi breast cancer reduc mortal due breast cancer fulli adjust hr num num confid interv num num num num num associ mark simvastatin num num num num num num conclus larg population-bas breast cancer cohort evid reduc mortal statin user breast cancer diagnosi associ weak magnitud attenu sensit analys	
MED-118~alkylphenol human milk relat dietari habit central taiwan pubm ncbi abstract aim studi determin concentr num nonylphenol np num octylphenol op num human milk sampl examin relat factor includ mother demograph dietari habit women consum median amount cook oil signific higher op concentr num ng/g consum num ng/g num op concentr signific consumpt cook oil beta num num fish oil capsul beta num num adjust age bodi mass index bmi np concentr signific consumpt fish oil capsul beta num num process fish product beta num num food pattern cook oil process meat product factor analysi strong op concentr human milk num determin aid suggest food consumpt nurs mother order protect infant np/op exposur num elsevi right reserv	
MED-557~dysmenorrhea pubm ncbi abstract dysmenorrhea lead recurr short-term school absenc adolesc girl common problem women reproduct age risk factor dysmenorrhea includ nullipar heavi menstrual flow smoke depress empir therapi initi base typic histori pain mens negat physic examin nonsteroid anti-inflammatori drug initi therapi choic patient presumpt primari dysmenorrhea oral contracept depo-medroxyprogesteron acet consid pain relief insuffici prolonged-cycl oral contracept intravagin oral contracept pill consid women desir hormon contracept evid benefit topic heat japanes herbal remedi toki-shakuyaku-san thiamin vitamin fish oil supplement low-fat vegetarian diet acupressur dysmenorrhea remain uncontrol approach pelvic ultrasonographi perform referr laparoscopi consid rule secondari dysmenorrhea patient sever refractori primari dysmenorrhea addit safe altern women conceiv includ transcutan electr nerv stimul acupunctur nifedipin terbutalin danazol leuprolid consid rare hysterectomi effect surgic interrupt pelvic nerv pathway establish	
MED-666~role surgeri treatment mastalgia pubm ncbi abstract breast pain common condit affect women stage reproduct life mastalgia resist treatment num cyclic num non-cycl patient surgeri wide treat condit consid patient sever mastalgia resist medic aim studi audit efficaci surgeri sever treatment resist mastalgia assess patient satisfact surgeri retrospect review medic record patient mastalgia clinic univers hospit wale cardiff num postal questionnair distribut patient undergon surgeri result show num patient mastalgia clinic num num undergon surgeri surgeri includ num subcutan mastectomi implant num bilater num unilater num bilater simpl mastectomi num quadrantectomi num simpl mastectomi median durat symptom num year rang num year patient num pain free surgeri num develop capsular contractur num wound infect dehisc pain persist patient undergo quadrantectomi conclud surgeri mastalgia consid minor patient patient inform complic inher reconstruct surgeri warn num case pain improv	
MED-691~ginger prevent nausea vomit review pubm ncbi abstract nausea vomit physiolog process experienc human stage life complex protect mechan symptom influenc emetogen respons stimuli symptom recur frequent signific reduc qualiti life detriment health exist antiemet agent ineffect stimuli expens possess side effect herbal medicin shown effect antiemet plant studi rhizom zingib officinal common ginger broad-spectrum antiemet tradit system medicin num year preclin clinic studi shown ginger possess antiemet effect emetogen stimuli conflict report prevent chemotherapy-induc nausea vomit motion sick prevent draw firm conclus current review time summar result attempt made address lacuna publish studi emphas aspect investig clinic futur	
MED-692~effect safeti ginger pregnancy-induc nausea vomit systemat review pubm ncbi abstract background ginger world therapeut agent centuri herb increas western societi common indic pregnancy-induc nausea vomit pnv object examin evid safeti effect ginger pnv method randomis control trial rcts ginger pnv sourc cinahl cochran librari medlin trip methodolog qualiti rcts assess critic apprais skill programm casp tool result rcts met inclus criteria trial found oral administ ginger signific effect placebo reduc frequenc vomit intens nausea advers event general mild infrequ conclus evid suggest ginger safe effect treatment pnv remain uncertainti maximum safe dosag ginger durat treatment consequ over-dosag potenti drug-herb interact import area futur research copyright num australian colleg midwiv publish elsevi right reserv	
MED-702~efficaci safeti liraglutid pubm ncbi abstract aim review systemat analyz efficaci safeti liraglutid treatment diabet mellitus comparison mono combin therapi method pubm date embas year search conduct liraglutid search term phase iii clinic trial retriev databas resourc post drug@fda websit evalu regard outcom efficaci safeti result phase iii clinic studi compar efficaci safeti liraglutid monotherapi combin liraglutid monotherapi dose num mg show signific superior reduct hba num compar monotherapi glimepirid glyburid liraglutid add-on therapi glimepirid dose num mg reduct hba num greater combin therapi glimepirid rosiglitazon liraglutid add-on therapi metformin fail show benefit combin metformin glimepirid tripl therapi liraglutid addit metformin glimepirid rosiglitazon result addit benefit hba num reduct common advers event gastrointestin disturb nausea vomit diarrhea constip clinic studi case pancreat case cancer report liraglutid arm case pancreat exenatid glimepirid arm case cancer metformin sitagliptin arm conclus liraglutid therapeut option improv glycem control patient type num diabet present lack evid durabl efficaci long-term safeti limit util general treatment type num diabet time	
MED-706~aqueous extract hibiscus sabdariffa calic modul product monocyt chemoattract protein num human pubm ncbi abstract diet supplement and/or modul import strategi signific improv human health search plant addit sourc bioactiv phenol compound relev context aqueous extract hibiscus sabdariffa rich anthocyanin phenol compound includ hydroxycitr chlorogen acid extract shown effect protect cultur peripher blood mononuclear cell cellular death induc num num signific role product inflammatori cytokin vitro extract promot product il num il num decreas concentr mcp num supernat dose-depend manner human ingest acut dose extract num toler decreas plasma mcp num concentr signific effect cytokin effect due concomit increas antioxid capac plasma mechan involv direct inhibit inflammatori and/or metabol pathway respons mcp num product relev inflammatori chronic condit role mcp num establish benefici effect confirm patient hibiscus sabdariffa consid valuabl tradit herbal medicin treatment chronic inflammatori diseas advantag devoid calor potenti alcohol toxic copyright num elsevi gmbh right reserv
MED-241~product food human relat cancer